Huixia Zhao

554 total citations
26 papers, 421 citations indexed

About

Huixia Zhao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Huixia Zhao has authored 26 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Huixia Zhao's work include RNA modifications and cancer (5 papers), Extracellular vesicles in disease (4 papers) and Ferroptosis and cancer prognosis (4 papers). Huixia Zhao is often cited by papers focused on RNA modifications and cancer (5 papers), Extracellular vesicles in disease (4 papers) and Ferroptosis and cancer prognosis (4 papers). Huixia Zhao collaborates with scholars based in China and United Kingdom. Huixia Zhao's co-authors include Wenhua Xiao, Jianhua Zhu, Weiwei Dong, Wenhua Xiao, Ming Ye, Guanghui Li, Xiaomei Li, Ping Yang, Shufang Zhang and Shufang Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Huixia Zhao

26 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huixia Zhao China 12 240 191 109 79 58 26 421
Anca Chelariu-Raicu Germany 12 179 0.7× 87 0.5× 142 1.3× 53 0.7× 32 0.6× 42 434
Yuxian Wei China 10 148 0.6× 83 0.4× 115 1.1× 64 0.8× 19 0.3× 27 322
Justyna Gil Poland 12 307 1.3× 117 0.6× 135 1.2× 59 0.7× 73 1.3× 38 488
Muhammad Usman Rashid Pakistan 15 261 1.1× 151 0.8× 179 1.6× 36 0.5× 148 2.6× 49 631
Yunyan Sun China 14 323 1.3× 122 0.6× 124 1.1× 53 0.7× 24 0.4× 32 546
Jianwei Zheng China 12 122 0.5× 61 0.3× 112 1.0× 63 0.8× 26 0.4× 47 387
Yimin Cai China 10 172 0.7× 103 0.5× 58 0.5× 48 0.6× 19 0.3× 31 310
Jinxiao Liang China 12 192 0.8× 83 0.4× 108 1.0× 53 0.7× 13 0.2× 24 366
Yuanfang Zhu China 11 456 1.9× 370 1.9× 43 0.4× 35 0.4× 18 0.3× 29 583
Jessica D. Lang United States 11 374 1.6× 90 0.5× 116 1.1× 31 0.4× 132 2.3× 24 493

Countries citing papers authored by Huixia Zhao

Since Specialization
Citations

This map shows the geographic impact of Huixia Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huixia Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huixia Zhao more than expected).

Fields of papers citing papers by Huixia Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huixia Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huixia Zhao. The network helps show where Huixia Zhao may publish in the future.

Co-authorship network of co-authors of Huixia Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Huixia Zhao. A scholar is included among the top collaborators of Huixia Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huixia Zhao. Huixia Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Yanyan, C. Chris Yun, Xi Li, et al.. (2025). Photothermal therapy combined with a STING agonist induces pyroptosis, and gasdermin D could be a new biomarker for guiding the treatment of pancreatic cancer. Journal of Translational Medicine. 23(1). 271–271. 3 indexed citations
2.
Dong, Weiwei, Huixia Zhao, He Zhang, et al.. (2023). Single-cell RNA sequencing and influences of necroptosis-associated myeloid lineages in immune microenvironment of PDAC.. Journal of Clinical Oncology. 41(16_suppl). e16261–e16261. 1 indexed citations
3.
Dong, Weiwei, Huixia Zhao, Li Wang, et al.. (2023). Single-cell RNA-seq analyses inform necroptosis-associated myeloid lineages influence the immune landscape of pancreas cancer. Frontiers in Immunology. 14. 1263633–1263633. 3 indexed citations
4.
Yang, Jingwen, He Zhang, Huixia Zhao, et al.. (2022). Exosomal microRNA panel as a diagnostic biomarker in patients with hepatocellular carcinoma. Frontiers in Cell and Developmental Biology. 10. 927251–927251. 11 indexed citations
5.
Liang, Min, et al.. (2022). Oxidation reaction and thermal stability of 1,3-butadiene under oxygen and initiator. Arabian Journal of Chemistry. 15(11). 104289–104289. 11 indexed citations
7.
Zhang, He, Weiwei Dong, Huixia Zhao, et al.. (2021). Homozygous deletion of the HLA-B gene as an acquired-resistance mechanism to nivolumab in a patient with lung adenocarcinoma: a case report. Annals of Translational Medicine. 9(19). 1506–1506. 4 indexed citations
8.
Li, Yajiao, Huiyu Li, Hua Wang, et al.. (2019). The proportion, origin and pro-inflammation roles of low density neutrophils in SFTS disease. BMC Infectious Diseases. 19(1). 109–109. 22 indexed citations
9.
Yang, Jingwen, Huixia Zhao, Fengyun Zhang, et al.. (2019). Double-Stranded DNA in Exosomes of Malignant Pleural Effusions as a Novel DNA Source for EGFR Mutation Detection in Lung Adenocarcinoma. Frontiers in Oncology. 9. 931–931. 36 indexed citations
10.
Wang, Ruliang, Jingwen Yang, Huixia Zhao, et al.. (2017). A transcriptome profile in hepatocellular carcinomas based on integrated analysis of microarray studies. Diagnostic Pathology. 12(1). 4–4. 24 indexed citations
11.
Hao, Yixin, Yongmei Li, Ming Ye, et al.. (2017). KRAS and BRAF mutations in serum exosomes from patients with colorectal cancer in a Chinese population. Oncology Letters. 13(5). 3608–3616. 40 indexed citations
12.
Fu, Qiang, Yanyan Guo, Ming Ye, et al.. (2017). Effectiveness of circulating tumor DNA for detection of KRAS gene mutations in colorectal cancer patients: a meta-analysis. OncoTargets and Therapy. Volume 10. 945–953. 28 indexed citations
13.
Li, Xiaomei, Wenhua Xiao, Ping Yang, & Huixia Zhao. (2017). Psychological distress and cancer pain: Results from a controlled cross-sectional survey in China. Scientific Reports. 7(1). 39397–39397. 42 indexed citations
14.
Li, Xiaomei, Weiwei Dong, Huixia Zhao, et al.. (2017). Molecular dysexpression in gastric cancer revealed by integrated analysis of transcriptome data. Oncology Letters. 13(5). 3177–3185. 5 indexed citations
15.
Xiao, Wenhua, et al.. (2015). Identification of commonly dysregulated genes in colorectal cancer by integrating analysis of RNA-Seq data and qRT-PCR validation. Cancer Gene Therapy. 22(5). 278–284. 30 indexed citations
16.
Li, Xiaomei, Pingping Li, Jinhui Wu, et al.. (2014). A preliminary report on adjuvant analgesic efficacy of HANS in opioid tolerant patients with cancer pain.. PubMed. 26(2). 174–82. 3 indexed citations
17.
Xiao, Wenhua, Huixia Zhao, Weiwei Dong, et al.. (2014). Quantitative detection of methylated NDRG4 gene as a candidate biomarker for diagnosis of colorectal cancer. Oncology Letters. 9(3). 1383–1387. 52 indexed citations
18.
Dong, Weiwei, Huixia Zhao, Caihong Zhang, et al.. (2014). Gene silencing of heparanase results in suppression of invasion and migration of hepatoma cells. World Journal of Surgical Oncology. 12(1). 85–85. 8 indexed citations
19.
Xiao, Wenhua, Weiwei Dong, Caihong Zhang, et al.. (2013). Effects of the epigenetic drug MS-275 on the release and function of exosome-related immune molecules in hepatocellular carcinoma cells. European journal of medical research. 18(1). 61–61. 58 indexed citations
20.
Wang, Hongyi, et al.. (2007). [Expression of CD133 in bone marrow cells of patients with leukemia and myelodysplastic syndrome].. PubMed. 15(3). 470–3. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026